On 12 November 2016 Amgen position (previous post) has been stopped out at USD 146.09. The realized profit is 4.65% before any taxes and fees.
3-year share price development of Amgen (USD)
On 2 November 2016 long position opened in Amgen at USD 139.6. Main underlying characteristics of the investment decision:
- recent share price drop pushed the stock price into oversold territory, but majority of the brokerage firms has buy or hold recommendation
- key global leading biotech player
- as an important result of its ongoing restructuring plan, in the future increase in margin is expected